ContraFect Completes $11.8 Million Financing
September 04, 2013 10:30 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that it has successfully closed a...
ContraFect Corporation Showcases CF-301 at ICAAC 2013 Meeting in Denver, CO
August 22, 2013 09:57 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 22, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that ContraFect has been selected to...
ContraFect to Present at the 5th Annual Biotech Showcase
January 04, 2013 09:13 ET | ContraFect Corporation
YONKERS, NY--(Marketwire - Jan 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert Nowinski, the Company's founder...
ContraFect to Present at the 11th Annual BIO Investor Forum
October 03, 2012 09:12 ET | ContraFect Corporation
YONKERS, NY--(Marketwire - Oct 3, 2012) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Julia P. Gregory, the Company's executive...
ContraFect Expands Senior Management Team
September 12, 2012 09:12 ET | ContraFect Corporation
YONKERS, NY--(Marketwire - Sep 12, 2012) - ContraFect Corporation announced today that it has expanded the senior management of the company with the addition of biotechnology veteran Julia Gregory...
ContraFect Announces Appointment of Sir Richard Sykes to Board of Directors
June 26, 2012 09:13 ET | ContraFect Corporation
YONKERS, NY--(Marketwire - Jun 26, 2012) - ContraFect Corporation announced today that Sir Richard Sykes, FRS, has joined the company's Board of Directors. Sir Richard has over 30 years of...
ContraFect Names Sol Barer Chairman of the Board
March 08, 2012 09:13 ET | ContraFect Corporation
YONKERS, NY--(Marketwire - Mar 8, 2012) - ContraFect Corporation announced today that Sol Barer, Ph.D. has been named the company's Chairman of the Board. Dr. Barer has been a director of...
ContraFect Corporation Completes Successful Pre-IND Meeting With FDA
December 14, 2011 09:13 ET | ContraFect Corporation
YONKERS, NY--(Marketwire - Dec 14, 2011) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, completed a...
ContraFect Hires David Huang, M.D., Ph.D. as Chief Medical Officer
November 15, 2011 09:13 ET | ContraFect Corporation
YONKERS, NY--(Marketwire - Nov 15, 2011) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, announced today that...
ContraFect Announces Agreement With The Rockefeller University for New Staph Lysin
September 21, 2011 09:13 ET | ContraFect Corporation
NEW YORK, NY--(Marketwire - Sep 21, 2011) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, announced that it...